版本:
中国

BRIEF-Ziopharm Oncology reports Q1 loss per share $0.15

May 1 Ziopharm Oncology Inc

* Ziopharm Oncology reports first quarter 2017 financial results and provides update on recent activities

* Q1 loss per share $0.15

* Q1 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S

* Ziopharm -ended quarter with cash and cash equivalents of about $66.4 million, which it believes will be sufficient to fund currently planned activities through Q4 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐